241,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
121 °P sammeln
  • Gebundenes Buch

The book unifies important topics relevant to both fields through a logical and systematic approach. It is intended to provide the principles of pharmacokinetics and toxicokinetics in a comprehensible, interrelated, and applied manner. It discusses the systematic overlapping of pharmacokinetics and toxicokinetics principles as well as the mathematics of modeling and interconnectivity between both topics. The systematic compilation of mathematical concepts and methodologies allows readers to decide on relevant concepts and approaches for their research, scientific or regulatory decisions, or for offering advance courses and seminars.…mehr

Produktbeschreibung
The book unifies important topics relevant to both fields through a logical and systematic approach. It is intended to provide the principles of pharmacokinetics and toxicokinetics in a comprehensible, interrelated, and applied manner. It discusses the systematic overlapping of pharmacokinetics and toxicokinetics principles as well as the mathematics of modeling and interconnectivity between both topics. The systematic compilation of mathematical concepts and methodologies allows readers to decide on relevant concepts and approaches for their research, scientific or regulatory decisions, or for offering advance courses and seminars.
Autorenporträt
Mehdi Boroujerdi is a professor of pharmaceutical sciences and the founding dean of the School of Pharmacy at the University of Massachusetts Lowell. He previously served as a professor, dean and provost of the Albany College of Pharmacy and Health Sciences in New York. He earned his PhD in pharmaceutics and pharmacokinetics from the University of North Carolina at Chapel Hill and conducted postdoctoral research at the National Institutes of Health - National Institute of Environmental Health Sciences (NIH-NIEHS) in chemical carcinogenesis and low-dose extrapolation. Dr. Boroujerdi has a broad background and experience in pharmacokinetics/toxicokinetics and the role of influx and efflux proteins. His current research explores the chemoresistance of pancreatic cancer cells to chemotherapeutic agents both in cell culture and in vivo. He has published more than 110 peer-reviewed articles as well as a textbook on pharmacokinetics, principles, and applications.